Research Article
A Comparative Study of Characteristics and Outcomes of Patients with Proved and Suggested Sarcoid Uveitis Occurring after Ophthalmic Procedure
Table 3
Comparison of postprocedure patients with control patients: demographic characteristics and ophthalmic, laboratory, and radiologic features.
| ā | Patients withocular surgery () | Controls () | value |
| Median age at diagnosis (years) | 69.7 | 52.7 | 0.004 | Females | 11 | 32 | 0.05 | Ethnicity Cau/Afr/North-Afr/As | 10/1/0/0 | 35/1/7/1 | 0.33 |
| Ophthalmologic findings | Unilateral/bilateral/unknown | 5/6/0 | 11/32/1 | 0.42 | Granulomatous | 9 | 20 | 0.07 | Synechiae | 1 | 20 | 0.05 | Elevated intraocular pressure | 1 | 2 | 0.26 | Retinal vasculitis | 2 | 5 | 0.50 | Macular edema | 8 | 18 | 0.16 | Papilledema | 2 | 6 | 0.51 | Multifocal choroiditis | 3 | 14 | 0.999 | Other ophthalmic features at diagnosis | 3 | 5 | 0.33 | Other systemic features at diagnosis | 2 | 11 | 1 | Other systemic features during course | 0 | 6 | 0.22 |
| Chest imaging | X-ray staging I/II/III/IV (scadding) | 7/1/3/0 | 23/17/3/1 | 0.08 |
| Serum markers | Elevated ACE | 7 | 18 | 0.65 | Elevated lysozyme | 6 | 22 | 0.999 |
| Treatment and outcome | Topical steroids | 8 | 35 | 0.27 | Systemic steroids | 6 | 25 | 0.27 | Immunosuppressants | 1 | 12 | 0.12 | Evolution to remission | 5 | 13 | 0.76 |
|
|
Cau = Caucasian, Afr = African, North-Afr = North African, As = Asian, and ACE = angiotensin-converting enzyme.
|